ImmunityBio, Inc. (formerly NantKwest, Inc.) is developing cell and immunotherapy products that are designed to help strengthen each patient’s natural immune system, potentially enabling it to outsmart the disease and eliminate cancerous or infected cells.

Biotechnology

ImmunityBio

Rich Adcock

Philip Loscalzo

Regan Lauer

Helen Luu

Patrick Soon-Shiong

Barry Simon

Jason Liljestrom

Sarah Singleton

Leonard S. Sender

David Sachs

The Clinical Operations Team at ImmunityBio manages and oversees clinical trials for cell and immunotherapy products. This includes trial planning, execution, and regulatory compliance to ensure the safety and efficacy of treatments aimed at enhancing the immune system's ability to combat cancer and infections.

Clinical Operations Team

Executive Team

Research and Development

Leadership Team

Clinical Operations Team

About

Team members

Other teams at ImmunityBio

Executive Team

Research and Development

Leadership Team